Insmed (NASDAQ:INSM) Coverage Initiated at Royal Bank of Canada
Equities researchers at Royal Bank of Canada started coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a research note issued on Tuesday, Marketbeat reports. The brokerage set an “outperform” rating and a $100.00 price target on the biopharmaceutical company’s stock. Royal Bank of Canada’s price objective suggests a potential upside of 28.04% […]
Equities researchers at Royal Bank of Canada started coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a research note issued on Tuesday, Marketbeat reports. The brokerage set an “outperform” rating and a $100.00 price target on the biopharmaceutical company’s stock. Royal Bank of Canada’s price objective suggests a potential upside of 28.04% […]
